PMV Pharmaceuticals, Inc. (PMVP)

USD 0.99

(-0.54%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 1.25 Million 650 Thousand 1.28 Million 318 Thousand 388 Thousand 338 Thousand
Gross Profit -1.25 Million -650 Thousand -1.28 Million -318 Thousand -388 Thousand -338 Thousand
Operating Expenses 80.13 Million 77.04 Million 58.29 Million 34.94 Million 26.63 Million 18.89 Million
Selling, General and Administrative Expenses 24.24 Million 25.05 Million 21.8 Million 11 Million 5.87 Million 5.03 Million
Research and Development Expenses 55.88 Million 51.98 Million 36.49 Million 23.93 Million 20.75 Million 13.85 Million
Other Expenses - 87 Thousand 21 Thousand -143 Thousand -8000.00 16 Thousand
Cost and Expenses 80.13 Million 77.04 Million 58.29 Million 34.94 Million 26.63 Million 18.89 Million
Operating Income -80.13 Million -77.04 Million -58.29 Million -34.94 Million -26.63 Million -18.89 Million
Interest Expense - - - - - -
Income Tax Expense 2000.00 -9000.00 23 Thousand 6000.00 8000.00 3000.00
Earnings before Tax -68.95 Million -73.32 Million -57.82 Million -34.43 Million -25.34 Million -17.53 Million
Net Income -68.96 Million -73.31 Million -57.84 Million -34.44 Million -25.35 Million -17.53 Million
Earnings Per Share Basic -1.44 -1.61 -1.28 -0.77 -0.59 -0.56
Earnings Per Share Diluted -1.44 -1.61 -1.28 -0.77 -0.59 -0.56
Weighted Average Shares Outstanding 48.01 Million 45.59 Million 45.13 Million 44.77 Million 42.99 Million 31.23 Million
Weighted Average Shares Outstanding (Diluted) 48.01 Million 45.59 Million 45.13 Million 44.77 Million 42.99 Million 31.23 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -78.87 Million -76.72 Million -57.98 Million -34.62 Million -26.24 Million -18.55 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts